Clinical Trials Browser

Phase 1 × Neoplasms × milademetan × Clear all

NCT03671564 2023-11-07

Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Phase 1 Completed

14 enrolled 14 charts

Other hematologic neoplasm

Neoplasms, Leukemia, Myeloid, Acute